Latest Period
Q1 2026
Security Snapshot
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) Institutional Ownership
CUSIP: 45168D104
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
1,306
Shares (Excl. Options)
71,544,024
Price
$561.89
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- IDXX on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 71,544,024
- Total 13F value
- $40,205,835,184
- Portfolio coverage rank
- 0.03%
- Share change
- -3,165,407
- Value change
- -$1,872,574,865
- Number of holders
- 1,306
- Shares outstanding
- 79,580,186
- SEC-reported price per share
- $557.21
- Insider filing price
- $557.21
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- IDXX - IDEXX LABORATORIES INC /DE - Common Stock is tracked under CUSIP 45168D104.
- 1306 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1,380 to 1,306 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $51,721,905,948 to $40,205,835,184.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 1306 institutions filings for Q1 2026.
Security key
45168D104
Latest holder period
Q1 2026
13F holders
1,306
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
IDXX full holder history
IDEXX LABORATORIES INC /DE SEC filings
IDEXX LABORATORIES INC /DE company facts
IDEXX LABORATORIES INC /DE insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45168D104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
IDXX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 9.4% | $3,297,923,861 | 7,599,078 | BlackRock, Inc. | 31 Mar 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 7.5% | $3,358,119,852 | 5,976,472 | Vanguard Capital Management | 31 Mar 2026 |
As of 31 Mar 2026, 1,306 institutional investors reported holding 71,544,024 shares of IDEXX LABORATORIES INC /DE - Common Stock (IDXX). This represents 90% of the company’s total 79,580,186 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
54%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11% | 8,365,553 | -2% | 0.08% | $4,700,520,591 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.5% | 5,182,507 | 0% | 0.07% | $2,911,998,858 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.9% | 3,910,863 | 0% | 0.11% | $2,197,474,811 |
| STATE STREET CORP | 4.6% | 3,674,185 | +0.48% | 0.07% | $2,064,487,810 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.3% | 2,660,999 | +3% | 0.09% | $1,497,768,297 |
| Invesco Ltd. | 2.1% | 1,678,556 | +12% | 0.14% | $943,164,096 |
| BAMCO INC /NY/ | 2.1% | 1,633,367 | -9.2% | 2.8% | $917,772,584 |
| Bank of New York Mellon Corp | 1.9% | 1,504,532 | -7.4% | 0.16% | $845,381,140 |
| Fundsmith LLP | 1.8% | 1,465,786 | -22% | 6.4% | $823,610,496 |
| MORGAN STANLEY | 1.7% | 1,315,954 | -15% | 0.04% | $739,423,426 |
| BLAIR WILLIAM & CO/IL | 1.2% | 946,336 | -5.5% | 1.5% | $531,736,581 |
| NORTHERN TRUST CORP | 1.1% | 911,893 | -1.2% | 0.07% | $512,383,559 |
| PRINCIPAL FINANCIAL GROUP INC | 1.1% | 881,189 | -9.1% | 0.26% | $495,164,014 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.1% | 871,789 | +1.4% | 0.1% | $489,849,521 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.1% | 838,839 | +52% | 0.26% | $471,335,246 |
| Capital Research Global Investors | 0.98% | 781,345 | +29% | 0.07% | $439,007,277 |
| JPMORGAN CHASE & CO | 0.98% | 779,882 | +16% | 0.03% | $434,464,824 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.92% | 735,475 | -5.6% | 0.08% | $413,256,047 |
| GOLDMAN SACHS GROUP INC | 0.9% | 716,921 | -14% | 0.05% | $402,830,921 |
| POLEN CAPITAL MANAGEMENT LLC | 0.87% | 695,811 | -28% | 2.7% | $390,969,243 |
| FRANKLIN RESOURCES INC | 0.83% | 662,633 | +5.7% | 0.09% | $372,326,527 |
| Legal & General Group Plc | 0.82% | 650,803 | -3% | 0.08% | $365,679,700 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.8% | 638,063 | -33% | 0.04% | $358,522,000 |
| Amundi | 0.77% | 610,779 | -1.3% | 0.09% | $343,190,612 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.77% | 610,217 | +3.4% | 0.05% | $342,874,830 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 71,544,024 | $40,205,835,184 | -$1,872,574,865 | $561.89 | 1,306 |
| 2025 Q4 | 75,208,804 | $51,721,905,948 | -$104,100,300 | $676.53 | 1,380 |
| 2025 Q3 | 72,156,674 | $46,076,126,465 | -$1,364,521,761 | $638.89 | 1,294 |
| 2025 Q2 | 74,492,454 | $39,944,909,126 | +$622,390,438 | $536.34 | 1,224 |
| 2025 Q1 | 73,764,672 | $30,958,486,481 | +$779,942,482 | $419.95 | 1,129 |
| 2024 Q4 | 71,835,659 | $29,724,021,447 | -$973,691,253 | $413.44 | 1,115 |
| 2024 Q3 | 72,771,836 | $36,698,542,671 | -$866,484,087 | $505.22 | 1,105 |
| 2024 Q2 | 74,742,498 | $36,407,539,797 | +$1,194,076,623 | $487.20 | 1,100 |
| 2024 Q1 | 72,528,628 | $39,086,467,213 | -$62,993,917 | $539.93 | 1,141 |
| 2023 Q4 | 72,729,572 | $40,349,913,998 | -$603,765,389 | $555.05 | 1,143 |
| 2023 Q3 | 74,019,658 | $32,363,649,715 | +$430,812,418 | $437.27 | 1,056 |
| 2023 Q2 | 73,042,621 | $36,667,385,940 | +$94,841,652 | $502.23 | 1,059 |
| 2023 Q1 | 72,713,915 | $36,334,265,012 | -$355,801,839 | $500.08 | 1,046 |
| 2022 Q4 | 73,497,514 | $30,011,391,318 | +$172,319,687 | $407.96 | 982 |
| 2022 Q3 | 73,626,131 | $24,002,744,883 | -$83,281,427 | $325.80 | 900 |
| 2022 Q2 | 73,767,652 | $25,881,144,178 | +$454,367,814 | $350.73 | 940 |
| 2022 Q1 | 72,572,264 | $39,690,896,632 | +$485,420,646 | $547.06 | 1,013 |
| 2021 Q4 | 71,508,034 | $47,013,671,922 | -$115,610,874 | $658.46 | 1,084 |
| 2021 Q3 | 71,564,445 | $44,507,146,691 | -$836,578,782 | $621.90 | 1,055 |
| 2021 Q2 | 72,890,084 | $46,029,916,801 | +$144,499,493 | $631.55 | 1,021 |
| 2021 Q1 | 72,631,314 | $35,536,251,001 | -$362,776,244 | $489.31 | 1,004 |
| 2020 Q4 | 73,683,435 | $36,820,146,126 | +$237,064,045 | $499.87 | 957 |
| 2020 Q3 | 73,270,641 | $28,787,297,170 | -$575,176,884 | $393.11 | 835 |
| 2020 Q2 | 74,703,783 | $24,698,206,219 | -$351,542,875 | $330.16 | 788 |
| 2020 Q1 | 75,867,270 | $18,376,382,067 | +$291,732,808 | $242.24 | 739 |